Correlation between serum laminin level and prognosis of acute heart failure

Xiaoyun Yan1, Jiaqi Ye1, Haixiao Chen1

  • 1Department of General Practice, Affiliated Hospital 2 of Nantong University, Nantong, China.

Clinical Cardiology
|May 31, 2023
PubMed

Insights

Elevated serum laminin (LN) levels are linked to major adverse cardiovascular events (MACE) in patients hospitalized with acute heart failure (AHF). This finding suggests LN may serve as a valuable biomarker for predicting poor AHF prognosis.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Acute heart failure (AHF) is a critical condition requiring accurate prognostic indicators.
  • Identifying reliable biomarkers for predicting adverse outcomes in AHF patients is essential for timely intervention.

Purpose of the Study:

  • To investigate the correlation between serum laminin (LN) levels and the prognosis of acute heart failure (AHF).
  • To evaluate the predictive value of LN for major adverse cardiovascular events (MACE) in hospitalized AHF patients.

Main Methods:

  • A cohort of 199 patients with AHF was studied.
  • Serum LN levels were measured, and patients were categorized based on MACE occurrence during hospitalization.
  • Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were employed.

Main Results:

  • The area under the ROC curve for LN predicting MACE was 0.8144 (p < .0001), with a sensitivity of 88.37%.
  • Increased LN levels were independently associated with MACE (OR: 1.020, 95% CI: 1.012-1.028).
  • Decreased ejection fraction and diastolic blood pressure were also independent predictors of MACE.

Conclusions:

  • Elevated serum LN levels are independently correlated with MACE in hospitalized AHF patients.
  • Serum LN shows potential as a serological indicator for poor prognosis in AHF.
Abstract

Related Concept Videos

Laminins are the Adhesive Proteins of Basal Lamina00:55

Laminins are the Adhesive Proteins of Basal Lamina

Laminins are heterotrimeric proteins with high molecular mass found in the extracellular matrix. Each laminin molecule is composed of three chains, viz. alpha, beta, and gamma, coded by five, four, and three paralogous genes, respectively. Laminins are categories based on the compositions of the three chains.
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
2.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
121
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
206